This post was originally published on this site
The software vendor posted Q4 earnings of $1.67 per share, $0.09 better than the analyst estimate of $1.58, while revenue for the quarter came in at $13.8 billion versus the consensus estimate of $13.74 billion.
Oracle shares are up more than 5% premarket, trading close to the $123 mark.
Here’s how Wall Street analysts reacted:
Goldman Sachs analysts said his firm is upgrading ORCL to Neutral with a $120 price target.
“We are upgrading Oracle to Neutral (from Sell) after a solid F4Q print and 1Q guide that alleviated concerns key to our Sell thesis, which centered primarily on mounting CapEx requirements to sustain growth in Gen2 OCI (while also diluting gross margin) and unabating market share losses in the Oracle’s core database business,” they wrote.
“Coming off the 4Q print, we were encouraged by the pronounced step-up in IaaS revenue growth to +77% (CC) vs. high-50’s from 1Q-3Q which we took as a clear signal that Oracle’s advertised price/performance advantage vs. the Hyperscalers is resonating w/ the market (both net new and existing customers), which should position the company for durable share gains despite its late entry into IaaS.”
Wolfe Research analysts maintained an Outperform rating but lifted the price target on ORCL to $140 from $130.
“ORCL reported a strong F4Q23 with OCI / IaaS Revenue, FCF, and EPS ahead of expectations. FY24 guidance on Cloud and IaaS were both ahead of our and investor expectations on the back of AI driving OCI tailwinds,” they said in a note.
Deutsche Bank analysts kept a Buy rating on the stock but raised the price target to $135 from $120.
“Oracle delivered strong F4Q results driven by robust demand across the portfolio and in particular, OCI accelerating to +77% y/y cc (from +57% last Q),” they stated. “Very importantly, the company expects to sustain its organic ~30% (ex Cerner) cloud growth rate in FY24, with upside dependent on the ability to roll out capacity.”
